Xometry, Inc.

For the period ended Dec 31, 2025. Filed Feb 24, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 24, 2026

XMTR$119.31-1.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Changes in Stockholders’ Equity

(In thousands, except share data)

Class A - Common Stock · Class B - Common Stock · Additional Paid-In · Treasury Stock · Accumulated Other Comprehensive · Accumulated · Total Stockholders’ · Noncontrolling · Total
	Shares	Amount	Shares	Amount	Capital	Shares	Amount	Income (Loss)	Deficit	Equity	Interest	Equity
Balance, December 31, 2022	44,822,264	$—	2,676,154	$—	$623,081	—	$—	$28	$(252,400)	$370,709	$1,090	$371,799
Exercise of common stock options	274,680	—	—	—	1,909	—	—	—	—	1,909	—	1,909
Vesting of restricted stock units	328,474	—	—	—	—	—	—	—	—	—	—	—
Shares issued in business combination	3,562	—	—	—	180	—	—	—	—	180	—	180
Donated common stock	60,399	—	—	—	1,029	—	—	—	—	1,029	—	1,029
Stock-based compensation	—	—	—	—	22,118	—	—	—	—	22,118	—	22,118
Comprehensive income:
Foreign currency translation	—	—	—	—	—	—	—	827	—	827	22	849
Net loss	—	—	—	—	—	—	—	—	(67,472)	(67,472)	7	(67,465)
Total comprehensive loss	—	—	—	—	—	—	—	827	(67,472)	(66,645)	29	(66,616)
Balance, December 31, 2023	45,489,379	$—	2,676,154	$—	$648,317	—	$—	$855	$(319,872)	$329,300	$1,119	$330,419
Conversion of stock	1,200,843	—	(1,200,843)	—	—	—	—	—	—	—	—	—
Exercise of common stock options	691,550	—	—	—	5,104	—	—	—	—	5,104	—	5,104
Vesting of restricted stock units	753,761	—	—	—	—	—	—	—	—	—	—	—
Exercise of warrants	52,126	—	—	—	—	—	—	—	—	—	—	—
Shares issued in business combination	21,083	—	—	—	625	—	—	—	—	625	—	625
Donated common stock	80,532	—	—	—	1,686	—	—	—	—	1,686	—	1,686
Stock-based compensation	—	—	—	—	29,322	—	—	—	—	29,322	—	29,322
Comprehensive income:
Foreign currency translation	—	—	—	—	—	—	—	(1,183)	—	(1,183)	26	(1,157)
Net loss	—	—	—	—	—	—	—	—	(50,401)	(50,401)	(2)	(50,403)
Total comprehensive loss	—	—	—	—	—	—	—	(1,183)	(50,401)	(51,584)	24	(51,560)
Balance, December 31, 2024	48,289,274	$—	1,475,311	$—	$685,054	—	$—	$(328)	$(370,273)	$314,453	$1,143	$315,596
Conversion of stock	—	—	—	—	—	—	—	—	—	—	—	—
Exercise of common stock options	367,250	—	—	—	3,087	—	—	—	—	3,087	—	3,087
Vesting of restricted stock units	1,309,442	—	—	—	—	—	—	—	—	—	—	—
Exercise of warrants	—	—	—	—	—	—	—	—	—	—	—	—
Shares issued in business combination	16,716	—	—	—	625	—	—	—	—	625	—	625
Donated common stock	80,532	—	—	—	3,272	—	—	—	—	3,272	—	3,272
Purchase of capped calls	—	—	—	—	(17,475)	—	—	—	—	(17,475)	—	(17,475)
Purchase of treasury stock	(220,994)	—	—	—	—	220,994	(8,080)	—	—	(8,080)	—	(8,080)
Stock-based compensation	—	—	—	—	36,362	—	—	—	—	36,362	—	36,362
Comprehensive income:
Foreign currency translation	—	—	—	—	—	—	—	5,100	—	5,100	(2)	5,098
Net loss	—	—	—	—	—	—	—	—	(61,743)	(61,743)	(5)	(61,748)
Total comprehensive loss	—	—	—	—	—	—	—	5,100	(61,743)	(56,643)	(7)	(56,650)
Balance, December 31, 2025	49,842,220	$—	1,475,311	$—	$710,925	220,994	$(8,080)	$4,772	$(432,016)	$275,601	$1,136	$276,737

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.